Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Stem Cell/Cord Blood Banking Market In 2029?
The market for stem cell/cord blood banking has seen robust growth in the previous years. The market will expand from $12.26 billion in 2024 to $13.33 billion in 2025, with a compound annual growth rate (CAGR) of 8.7%. The growth observed in the historic period resulted from progresses in medicine, enhanced awareness, fruitful clinical applications, regulatory backing, and research funding.
Rapid expansion is anticipated in the stem cell/cord blood banking market in the coming years, with its size projected to reach $21.6 billion in 2029, boasting a compound annual growth rate (CAGR) of 12.8%. The growth during the projected period is ascribed to factors like personalized medicine, emerging therapies, global expansion, biotechnology investments, and a legal and ethical framework. Significant trends observed during the forecast period encompass non-invasive collection procedures, a variety of banking services, transparency and regulation, cooperative initiatives, and advancements in storage.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2514&type=smp
What are the Fundamental Drivers and Innovations Shaping the Stem Cell/Cord Blood Banking Market?
The escalating count of individuals suffering from cancer is a significant catalyst propelling the growth of the stem cell/cord blood banking market. Cancer-related diseases such as leukemia and multiple myeloma can be confronted effectively with stem cell transplants. The transplant can be performed either autologously, meaning the stem cells are sourced from the recipient themselves, or allogeneically, implying the cells come from a related or unrelated donor who is a match. Implementing stem cells in cancer treatment allows for the replenishment of blood-forming stem cells that are harmed during chemotherapy. As an illustration, the American Cancer Society, a US-based non-profit devoted to cancer advocacy, reported in January 2023, an upsurge in cancer cases to 1,958,310 from 1,898,160 in 2021, indicating a 3.16% growth. Hence, the rising prevalence of cancer patients is fuelling the surge of the stem cell/cord blood banking market.
How Is the Stem Cell/Cord Blood Banking Market Segmented?
The stem cell/cord blood bankingmarket covered in this report is segmented –
1) By Cell Type: Adult Stem Cells; Umbilical Cord Blood Stem Cells; Embryonic Stem Cells
2) By Service: Collection; Processing; Analysis; Storage
3) By Bank Type: Public; Private
4) By Application: Leukemia; Anemia; Thalassemia; Autism; Cerebral Palsy; Diabetes; Other Applications
Subsegments:
1) By Adult Stem Cells: Hematopoietic Stem Cells (HSC); Mesenchymal Stem Cells (MSC); Neural Stem Cells (NSC); Induced Pluripotent Stem Cells (iPSCs)
2) By Umbilical Cord Blood Stem Cells: Hematopoietic Stem Cells (HSC) From Cord Blood; Mesenchymal Stem Cells (MSC) From Cord Blood
3) By Embryonic Stem Cells: Embryonic Stem Cells (ESCs) From Human Embryos; Stem Cells Derived From Human Embryonic Germ Cells
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=2514&type=smp
Which Regions Are Driving the Next Phase of the Stem Cell/Cord Blood Banking Market Growth?
North America was the largest region in the stem cell/cord blood banking market in 2024. Western Europe was the second largest region in the stem cell/cord blood banking market analysis. The regions covered in the stem cell/cord blood banking market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Key Trends Are Shaping the Future of the Stem Cell/Cord Blood Banking Market?
The association of cord blood and tissue storage with genomic testing is a burgeoning trend in the stem cell/cord blood banking industry. This combination is feasible and effective as it offers additional services to the current clientele, thereby assisting in the enhancement of their product collection. An illustration of this is Natera, a genetic testing enterprise, initiating the Evercord cord blood and tissue storage service. This allows future parents to gather, preserve, and possibly recover their newborn’s cord blood and tissue for potential use in transplantation and regenerative medicinal procedures.
View the full report here:
https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report
How Is the Stem Cell/Cord Blood Banking Market Defined and What Are Its Core Parameters?
Stem cell or cord blood banking is the process of storing stem cells or blood from the umbilical cord. It is used to treat future injuries. By taking stem cells from the placenta and umbilical cord and preserving them for later use, cord blood banking can possibly save lives.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2514
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
